Controlled Release Drug Delivery Market Overview
Controlled release drug delivery involves releasing drug through drug-encapsulating devices at controlled rates for long periods to facilitate optimal use of drugs and tailoring of drug release rates. Controlled release drug delivery aids in achieving more efficacy in therapies while alleviating the potential for both overdosing and underdosing. The global controlled release drug delivery market was valued at USD 31.96 Bn and is expected to catapult to USD 70.15 Bn at a CAGR of 14% during the forecast period, asserts Market Research Future (MRFR) in a detailed study.
Controlled release drug delivery system offers several benefits like lower dose requirement, improved stability of the drug, enhanced drug safety and efficacy, minimum side effects, improved patient compliance, and higher bioavailability. These benefits are influencing the adoption of these systems globally. This system also allows dose reduction, which minimizes the risk of overdose, especially in the aging population. Such factors are likely to provide fillip Controlled Release Drug Delivery Market. The unpleasant taste of dysphagia or pediatric medication for aging population will elevate the scope of the market in the long run.
Controlled release drug delivery is an advanced drug administration technique. In this, a drug with uniform dose is delivered at a targeted site to achieve the required therapeutic action. The increase in geriatric and pediatric population, the increase in prevalence of chronic diseases, and the need for administrating required dose are factors bolstering the global controlled release drug delivery market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6794
Controlled Release Drug Delivery Market Segmentation
The global controlled release drug delivery market is segmented on the basis of route of administration, release mechanism, products, and end users.
By route of administration the market is segmented into nasal, oral, ocular, topical, implantable, and injectable. The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal.
On the basis of the release mechanism, the market is segmented into activation modulated drug delivery systems, polymer-based drug delivery systems, feedback-regulated drug delivery systems, micro-reservoir partition-controlled drug delivery systems, and chemically activated controlled drug delivery systems. The activation modulated drug delivery systems are sub-segmented into osmotic pressure activated drug delivery, magnetically activated drug, hydrodynamic pressure activated drug delivery, mechanically activated drug, and vapor pressure activated drug delivery. The chemically activated controlled drug delivery systems are sub-segmented into enzyme activated drug delivery, pH-activated drug delivery, and hydrolysis activated drug delivery.
By product, the market is segmented into transdermal patches, auto-injectors, metered dose inhalers, needle-free injectors, drug-eluting stents, nasal sprays, nebulizers, infusion pumps, ocular implants, and sustained release.
By end user, the market is segmented into research centers, hospital and clinics, personal use, and others.
Controlled Release Drug Delivery Market Regional Analysis
Based on the region, the controlled release drug delivery market covers growth opportunities and latest trends across the Americas, Asia Pacific, Europe, and the Middle East & Africa.
Considering the global scenario, the Americas is considered to command the largest market share, with North America expected to dominate the market in the coming years. The growth can be ascribed to the surging cases of several diseases like Alzheimer’s and gastrointestinal diseases. Rising research and development activities, advanced infrastructure in the pharmaceutical industry, and the existence of robust pharmaceutical companies in North America will encourage the market growth.
Europe has managed to seize the second-largest share in the global market due to the increased incidence of respiratory diseases and hypertension among individuals. The rising number of patients with chronic diseases like cancer, CPOD, and diabetes will further elevate the scope of the market in Europe.
Meanwhile, the Asia Pacific is estimated to register the fastest growth due to the ever-increasing geriatric population, which has resulted in an increased demand for controlled doses to minimize the toxicity level and side effects in the patients. Moreover, the rapid expansion identified in the Chinese and Indian pharmaceutical industry will propel the market growth in the region.
Controlled Release Drug Delivery Market Players
· Corium International Inc.(US)
· Alza Corporation (Johnson & Johnson)(US)
· Pfizer Inc.(US)
· SKY Pharmaceuticals Pvt. Ltd.(China)
· AstraZeneca (US)
· Biogen (US)
· GlaxoSmithKline (UK)
· Novartis (UK)
· Allergan (Ireland)
· Collegium Pharmaceutical (US)
· Others
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/controlled-release-drug-delivery-market-6794
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: [email protected]
Global Controlled Release Drug Delivery Market Research Report, by Route of administration (Transdermal, Oral), Release Mechanism (Polymer-based, Micro reservoir Partition), Products (Metered Dose Inhalers), End User (Hospital)— Forecast till 2023Controlled release drug delivery is a method of doling out drugs in required doses to patients.
Market Research Future (MRFR) has compiled the topmost trends, opportunities, and growth drivers of the global controlled release drug delivery market report with forecasts for the period between 2017 and 2023.Controlled Release Drug Delivery Market OutlookThe Global Advanced Controlled Release Drug Delivery Market is set to achieve a jump in valuation from USD 31.96 billion in 2017 to USD 70.15 billion by 2023, according to MRFR.
Key factors driving market growth include rising cases of patient deaths due to overdose, health problems from high doses, and rising R efforts in the healthcare industry.
Advantages pertaining to the technology such as reduction of toxin accumulation, acclimatization of patients to the dose rate, and stability of the medical condition can influence the controlled drug delivery market demand.Low awareness of the technology and high costs per dose can negatively impact the market growth trajectory.Controlled Release Drug Delivery Market Competitive LandscapeAllergan, SKY Pharmaceuticals Pvt.
Ltd., Alza Corporation (Johnson & Johnson), Novartis, Depomed, Inc. (US), AstraZeneca, Collegium Pharmaceutical, GlaxoSmithKline, Pfizer Inc., Corium International Inc., Coating Place, Inc., Biogen, and others are key market participants.Controlled Release Drug Delivery Market SegmentationThe global controlled release drug delivery market is segmented on the basis of route of administration, release mechanism, products, and end users.By route of administration the market is segmented into nasal, oral, ocular, topical, implantable, and injectable.
The injectable is sub-segmented into targeted delivery, transmucosal, and transdermal.On the basis of the release mechanism, the market is segmented into activation modulated drug delivery systems, polymer-based drug delivery systems, feedback-regulated drug delivery systems, micro-reservoir partition-controlled drug delivery systems, and chemically activated controlled drug delivery systems.
Global Controlled Release Drug Delivery Market is expected to reach USD 90.18 billion by 2025.
The controlled release drug delivery market is estimated to grow at a significant CAGR of 13.8% over the future period as the scope and its applications are rising enormously across the globe.
Controlled release drug delivery market is segmented based on technology, mechanism, application, and region.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/controlled-release-drug-delivery-market/request-sampleHighly enhanced technology used includes Targeted Delivery, Wurster Technique, Transdermal, Coacervation, Implants, Micro Encapsulation, and others that could be explored in controlled release drug delivery market in the future period.
Targeted delivery sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
However, micro encapsulation sector is estimated to grow at fastest pace in the coming years.Chemically Activated, Polymer Matrix Based Systems, Activation-modulated Drug Delivery Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, and Feedback Regulated Drug Delivery Systems are the release mechanisms that could be explored in controlled release drug delivery market in the forecast period.
Chemically activated sector accounted for the largest market share of controlled release drug delivery and is estimated to lead the overall market in the coming years.
